In addition, activation of PAR2 is involved in several pathological pain states as was demonstrated in inflammatory [4], bone cancer [36], chemotherapeutic agent-induced pain [18] or osteoarthritis [44]. The gene discussed is F2RL1; the disease is bone cancer.